[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335329-105":59,"doc-detail-335329-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","metabolic-reprogramming-of-the-tumor-microenvironment-to-enhance-immunotherapy","Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy","","Immunotherapy targets diverse tumor types, yet response rates remain limited because the tumor microenvironment (TME) actively drives immunosuppression that restricts anticancer immune activity. Metabolic reprogramming in tumors has emerged as a key mechanism for shaping the TME and strengthening immune cell responses. The review highlights how metabolic limitations imposed by the TME govern antitumor immune-cell effectiveness, motivating new therapeutic strategies. It summarizes metabolic barriers, metabolite-based immune regulation, and current approaches using metabolic targeting to both inhibit tumors and enhance immune responses.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/metabolic-reprogramming-of-the-tumor-microenvironment-to-enhance-immunotherapy/335329/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/metabolic-reprogramming-of-the-tumor-microenvironment-to-enhance-immunotherapy/335329.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is the overall response rate of immunotherapy limited?","Question",{"text":112,"@type":113},"The tumor microenvironment (TME) induces immunosuppression through many distinct factors, which restricts anticancer immune reactions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does metabolic reprogramming influence immunotherapy?",{"text":117,"@type":113},"Metabolic reprogramming modulates the TME and affects metabolic limitations that determine how well antitumor immune cells function.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the review plan to cover regarding metabolic targeting?",{"text":121,"@type":113},"It discusses metabolic barriers in the TME, how immune response is regulated by metabolites, and strategies to target metabolism to enhance antitumor immune responses in addition to inhibiting tumor growth.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335329,1790196736,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":4},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","BMB Reports  \nBMB Rep. 2024; 57(9): 388-399  \n[www.bmbreports.org](www.bmbreports.org)  \n Invited Mini Review   \nMetabolic reprogramming of the tumor microenvironment to enhance immunotherapy  \nSeon Ah Lim1,2, *  \n1Department of Life Science, Ewha Womans University, Seoul 03760, 2Research Center for Cellular Homeostasis, Ewha Womans University, Seoul 03760, Korea  \nImmunotherapy represents a promising treatment strategy for targeting various tumor types. However, the overall response rate is low due to the tumor microenvironment (TME). In the TME, numerous distinct factors actively induce immunosuppression, restricting the efficacy of anticancer immune reactions. Recently, metabolic reprogramming of tumors has been recognized for its role in modulating the tumor microenvironment to enhance immune cell responses in the TME. Furthermore, recent elucidations underscore the critical role of metabolic limitations imposed by the tumor microenvironment on the effectiveness of antitumor immune cells, guiding the development of novel immunotherapeutic approaches. Hence, achieving a comprehensive understanding of the metabolic requirements of both cancer and immune cells within the TME is pivotal. This insight not only aids in acknowledging the current limitations of clinical practices but also significantly shapes the trajectory of future research endeavors in the domain of cancer immunotherapy. In addition, therapeutic interventions targeting metabolic limitations have exhibited promising potential as combinatory treatments across diverse cancer types. In this review, we first discuss the metabolic barriers in the TME. Second, we explore how the immune response is regulated by metabolites. Finally, we will review the current strategy for targeting metabolism to not simply inhibit tumor growth but also enhance antitumor immune responses. Thus, we could suggest potent combination therapy for improving immunotherapy with metabolic inhibitors.[BMB Reports 2024; 57(9): 388-399]  \nINTRODUCTION  \nMetabolic reprogramming is ability of cancer cells to modify  \n*Corresponding author. Tel: +82-2-3277-3494; Fax: +82-2-3277-3760; E-mail: [seonlim@ewha.ac.kr](seonlim@ewha.ac.kr)  \n[https://doi.org/10.5483/BMBRep.2024-0031](https://doi.org/10.5483/BMBRep.2024-0031)  \nReceived 5 February 2024, Revised 27 March 2024, Accepted 21 June 2024, Published online 16 July 2024  \nKeywords: Immune checkpoint inhibitor, Immunotherapy, Metabolic reprogramming, Metabolism, Tumor microenvironment  \ntheir metabolism and it is one of the hallmarks of tumor that is distinct feature compares with non-cancerous cells (1) . This is further defined by the enhancement of absorption and utilization of carbohydrates, lipids, and proteins, resulting in a pro-tumorigenic response concurrent with the acquisition and maintenance of malignant properties. Various factors contribute to this metabolic shift, including the influence of oncogenes, growth factors, hypoxia, and tumor suppressor genes (1, 2) . These alterations lead to significant changes in cell metabolism, particularly in glucose, with a marked increase in its absorption rate in cancer cells. For this notion, anti-metabolites therapies have been developed for cancer treatment and some of metabolic inhibitors were developed for cancer cell derangement and can regulate some tumor development. However, for many other observed metabolic derangements in tumor cells, clinical translation has been more challenging. Reasons for this hurdle include the flexibility of cancer metabolic pathways to circumvent points of inhibition, leading to insufficiency of monotherapy; overlap with metabolism of healthy cells, which narrows the therapeutic index; and the difficulty of accessing some tumors of interest—particularly CNS tumors or tumors within a dense environment of supporting cells. Moreover, Metabolic inhibitors can reshape the TME by altering the availability of nutrients and metabolites and this can influence the composition a","cbCaicaPfTpIMf1S","https://ap.wps.com/l/cbCaicaPfTpIMf1S","pdf",11800346,12,"English","# Introduction\n## Metabolic reprogramming and metabolic barriers in the TME\n## Challenges of metabolic-target monotherapy\n## Metabolites as regulators of immune evasion\n# Brief Summary of Immunotherapy\n## Immune checkpoint inhibitors and resistance hurdles\n## Targeting tumor metabolites to reshape the TME","[{\"question\":\"Why is the overall response rate of immunotherapy limited?\",\"answer\":\"The tumor microenvironment (TME) induces immunosuppression through many distinct factors, which restricts anticancer immune reactions.\"},{\"question\":\"How does metabolic reprogramming influence immunotherapy?\",\"answer\":\"Metabolic reprogramming modulates the TME and affects metabolic limitations that determine how well antitumor immune cells function.\"},{\"question\":\"What does the review plan to cover regarding metabolic targeting?\",\"answer\":\"It discusses metabolic barriers in the TME, how immune response is regulated by metabolites, and strategies to target metabolism to enhance antitumor immune responses in addition to inhibiting tumor growth.\"}]","Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy | PDF",1790010556]